Transplantation Direct (Oct 2021)

Successful Liver Transplantation in a Patient With Acute COVID-19 Infection and Acute Liver Failure: A Case Report

  • Kristen M. Kidson, MD, FRCPC,
  • Jeieung Park, MD, FRCPC,
  • Marthe K. Charles, MD, MSc, FRCPC,
  • Mahmoud Omar, MD, MSc,
  • Mel Krajden, MD, FRCPC,
  • Alissa J. Wright, MD, MSc, FRCPC,
  • Trana Hussaini, PharmD,
  • Peter T. W. Kim, MD, MSc, FRCSC,
  • Stephen W. Chung, MD, PhD, FRCSC,
  • Eric M. Yoshida, MD, MHSc, FRCPC

DOI
https://doi.org/10.1097/TXD.0000000000001210
Journal volume & issue
Vol. 7, no. 10
p. e747

Abstract

Read online

Current liver transplantation societies recommend recipients with active coronavirus disease 2019 (COVID-19) be deferred from transplantation for at least 2 wks, have symptom resolution and at least 1 negative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test.1 This approach does not address patients who require urgent transplantation and will otherwise die from liver failure. We report a successful orthotopic liver transplant (OLT) in a patient with active COVID-19 infection. This is only the second to be reported worldwide and the first in Canada.